HER-Vaxx has successfully completed a Phase I study in breast cancer and the next stage of development will be a Phase II study in gastric cancer.

Dr. Yelena Janjigian

Dr. Yelena Janjigian is a medical oncologist at the Memorial Sloan Kettering Cancer Center, the oldest and largest private cancer centre in the US.  Dr. Janjigian specializes in the treatment of malignancies of the gastrointestinal tract, including esophagus and stomach cancers. Her research focuses on the development of new treatments for patients with esophagus and stomach cancers, and is particularly interested in finding ways to select the best treatments for persons with cancer based on the molecular characteristics of their tumor specimens. Dr. Janjigian runs clinical and translational studies designed to develop a better prevention, early diagnosis, staging, and treatment strategies. She is the Principal Investigator on a number of clinical trials at Memorial Sloan Kettering.  Dr. Janjigian received her doctorate in medicne from New York University School of Medicine.   Dr. Janjigian holds board certifications for internal medicine and medical oncology.


© Imugene 2018. All rights reserved. ABN 99 009 179 551